ifinatamab deruxtecan

News mentioning ifinatamab deruxtecan · Wikidata · RSS

Top stories

Latest

1. Merck and Daiichi Sankyo withdraw FDA approval application for new lung cancer drug 'Ifinatamab Deruxtecan'cdn.pharmnews.com · 2026-09-28 00:11 UTC · story